140 related articles for article (PubMed ID: 22369147)
1. 3-aminopiperidine-based peptide analogues as the first selective noncovalent inhibitors of the bacterial cysteine protease IdeS.
Berggren K; Vindebro R; Bergström C; Spoerry C; Persson H; Fex T; Kihlberg J; von Pawel-Rammingen U; Luthman K
J Med Chem; 2012 Mar; 55(6):2549-60. PubMed ID: 22369147
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding.
Vincents B; von Pawel-Rammingen U; Björck L; Abrahamson M
Biochemistry; 2004 Dec; 43(49):15540-9. PubMed ID: 15581366
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
[TBL] [Abstract][Full Text] [Related]
4. Identification and Co-complex Structure of a New S. pyogenes SpeB Small Molecule Inhibitor.
Wang AY; González-Páez GE; Wolan DW
Biochemistry; 2015 Jul; 54(28):4365-73. PubMed ID: 26132413
[TBL] [Abstract][Full Text] [Related]
5. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG.
Wenig K; Chatwell L; von Pawel-Rammingen U; Björck L; Huber R; Sondermann P
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17371-6. PubMed ID: 15574492
[TBL] [Abstract][Full Text] [Related]
6. IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection.
Akesson P; Moritz L; Truedsson M; Christensson B; von Pawel-Rammingen U
Infect Immun; 2006 Jan; 74(1):497-503. PubMed ID: 16369006
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing of the streptococcal IgG endopeptidase IdeS modulates the functional properties of the enzyme and results in reduced immunorecognition.
Persson H; Söderberg JJ; Vindebro R; Johansson BP; von Pawel-Rammingen U
Mol Immunol; 2015 Dec; 68(2 Pt A):176-84. PubMed ID: 26343448
[TBL] [Abstract][Full Text] [Related]
8. IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies.
Frick IM; Happonen L; Wrighton S; Nordenfelt P; Björck L
J Biol Chem; 2023 Nov; 299(11):105345. PubMed ID: 37838172
[TBL] [Abstract][Full Text] [Related]
9. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.
von Pawel-Rammingen U; Johansson BP; Björck L
EMBO J; 2002 Apr; 21(7):1607-15. PubMed ID: 11927545
[TBL] [Abstract][Full Text] [Related]
10. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin cleavage by the streptococcal cysteine protease IdeS can be detected using protein G capture and mass spectrometry.
Hess JL; Porsch EA; Shertz CA; Boyle MD
J Microbiol Methods; 2007 Aug; 70(2):284-91. PubMed ID: 17543400
[TBL] [Abstract][Full Text] [Related]
12. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
13. SpeB-Spi: a novel protease-inhibitor pair from Streptococcus pyogenes.
Kagawa TF; O'toole PW; Cooney JC
Mol Microbiol; 2005 Aug; 57(3):650-66. PubMed ID: 16045611
[TBL] [Abstract][Full Text] [Related]
14. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity.
Allhorn M; Olsén A; Collin M
BMC Microbiol; 2008 Jan; 8():3. PubMed ID: 18182097
[TBL] [Abstract][Full Text] [Related]
15. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.
Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M
Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671
[TBL] [Abstract][Full Text] [Related]
16. An Irreversible Inhibitor to Probe the Role of
Woehl JL; Kitamura S; Dillon N; Han Z; Edgar LJ; Nizet V; Wolan DW
ACS Chem Biol; 2020 Aug; 15(8):2060-2069. PubMed ID: 32662975
[TBL] [Abstract][Full Text] [Related]
17. IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes.
von Pawel-Rammingen U; Björck L
Curr Opin Microbiol; 2003 Feb; 6(1):50-5. PubMed ID: 12615219
[TBL] [Abstract][Full Text] [Related]
18. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
[TBL] [Abstract][Full Text] [Related]
19. Generating and Purifying Fab Fragments from Human and Mouse IgG Using the Bacterial Enzymes IdeS, SpeB and Kgp.
Sjögren J; Andersson L; Mejàre M; Olsson F
Methods Mol Biol; 2017; 1535():319-329. PubMed ID: 27914089
[TBL] [Abstract][Full Text] [Related]
20. Blocking of experimental arthritis by cleavage of IgG antibodies in vivo.
Nandakumar KS; Johansson BP; Björck L; Holmdahl R
Arthritis Rheum; 2007 Oct; 56(10):3253-60. PubMed ID: 17907170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
